COVID-19 seminars: Next seminar 9.11. at 12
The seminars bring together Finnish researchers who are active in COVID-19 research and the general audience who are interested in COVID-19 related research. Check all the dates and keynote speakers on this site.

Welcome to the series of COVID-19 related research seminars at the University of Helsinki!

COVID-19 seminars will be organized once in a month. The seminars will feature two keynote talks (30 min. each). The events are in English.

The seminars will be supported by the Faculty of Medicine and hosted by Professor Olli Vapalahti with co-hosts, Associate Professor Tarja Sironen and Postdoctoral Researcher Ravi Kant. Due to the current ongoing pandemic and recommendations by University of Helsinki, the seminars will be held in remote mode via Zoom.

Zoom-link for seminars: https://helsinki.zoom.us/j/65882013425?pwd=a2dBY1V5YjkrcTVDUTQwL3JFQ1pDZz09
Meeting ID: 658 8201 3425
Passcode: 123456
 

Upcoming seminars:
 

9.11.2021 at 12:

Covid-19 vaccinations in children and adolescents
Mika Rämet, Professor, Director of Vaccine Research Center, Tampere University

Introduction, evolution, and circulation of SARS-CoV-2 in Finland
Teemu Smura, Postdoctoral researcher, University of Helsinki
 

Past seminars:

5.10.2021 

SARS-CoV-2 immune responses and transmission
Jonas Klingström
, Professor, Karolinska Institutet

A mouse model of lethal respiratory dysfunction for SARS-CoV-2 infection
Esther Gan, Postdoctoral Research Fellow, Duke-NUS Medical School, Singapore

7.9.2021

Development of SARS-CoV-2 clinical laboratory diagnostics
Satu Kurkela, Chief Physician, HUS Diagnostic Center

SARS-CoV-2 variants and vaccine-induced immunity
Laura Kakkola, Docent, University of Turku

26.5.2021 

Of mice and men? Sure, but don't forget the hamster...
A pathologist's view of some animal models for COVID-19

Anja Kipar, Professor, Institute of Veterinary Pathology, Vetsuisse Faculty, University of Zurich

COVID modelling: examples of tasks in THL
Simopekka Vänskä,
Docent, University of Helsinki, Senior Researcher, Finnish Institute for Health and Welfare

13.4.2021 

What do we know about the impact of covid-19 vaccines?
Hanna Nohynek, Chief Physician, Unit: Infectious Diseases Control and Vaccines, Finnish Institute for Health and Welfare

COVID-19 and convalescent plasma: what have we learnt so far?
Heli J. Harvala, Medical Virology Consultant, NHS Blood and Transplant, Adjunct Professor in Molecular Virology, University of Turku

23.3.2021 

Engineered antibodies to combat COVID-19
Ilona Rissanen, Postdoctoral Researcher, University of Helsinki

Substrate-selective protein secretion inhibition as a disease-agnostic strategy also against Covid-19
Ville Paavilainen, Docent, Group Leader, University of Helsinki

16.2.2021 

The COVID-19 host genetics initiative: a global effort to identify genetic factors of COVID-19 susceptibility, severity, and outcomes across > 200 studies worldwide
Andrea Ganna, EMBL-group leader at FIMM, University of Helsinki

Coagulation and inflammation - implications in COVID-19
Riitta Lassila, Professor in Coagulation Medicine, University of Helsinki

19.1.2021 

COVID-19 immunity
Ilkka Julkunen
, Professor, Institute of Biomedicine, University of Turku

Wastewater-based surveillance of SARS-CoV-2
Tarja Pitkänen, Associate Professor (environmental health), University of Helsinki, Chief Specialist, Finnish Institute for Health and Welfare 

8.12.2020 

Adenovectored COVID-19 vaccine
Kalle Saksela, Professor, University of Helsinki
The Deparment of Virology

Hijacking the host cell molecular highways
Markku Varjosalo, Research Director, University of Helsinki
Research group: Molecular Systems Biology

10.11.2020 

Antibodies against SARS-CoV-2 - are they there and for how long?
Jussi Hepojoki
, Academy Research Fellow, University of Helsinki
Research group: Viral Zoonooses Research Unit

Airborne transmission of viruses: aerosol dispersion in public places by fast assessment
Ville Vuorinen, Assistant Professor, Aalto University

6.10.2020
 

The dogs’ nose knows SARS-CoV-2
Anna Hielm-Björkman, Adjunct Professor, University of Helsinki
Research group: DogRisk

Low-density neutrophils in COVID-19
Tomas Strandin, Academy Research Fellow, University of Helsinki
Research group: Viral Zoonooses Research Unit

7.9.2020
 

Watch the recording in Unitube

Open Sesame: how SARS-CoV-2 enters and spreads in human cells
Giuseppe Balistreri, Academy Research Fellow, University of Helsinki
Research group: Viral Cell Biology 

Genetic diversity of SARS-CoV-2
Teemu Smura, Senior Scientist, University of Helsinki
Research group: Viral Zoonooses Research Unit 

More information: 

Ravi Kant, Postdoctoral Reseacher, University of Helsinki
ravi.kant@helsinki.fi